
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [ABBV] AbbVie, Inc.
Data updated 2024-Dec-19 (Thursday)Compare current performance/technical metrics to history for AbbVie, Inc.. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2024-Dec-19 Thursday
Day Change | -0.87% Low | Day Volatility | 2.08% Mid |
Streak | ↓ 2 days Low | % Streak | -2.20% Low |
RSI | 38 Low | CCI | -101.1 Low |
MACD | 0.04 Mid | ATR | 3.84 Top |
ADX | 22.0 Mid | SSO | 21.1 Low |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | -0.96% Mid | 3.70% Mid | -0.85% Low |
10-day | -2.64% Low | 4.65% Low | -1.48% Low |
20-day | +2.24% Mid | 10.38% Mid | -2.81% Low |
50-day | -11.93% Low | 26.56% Top | -6.34% Low |
100-day | -8.17% Low | 26.56% Mid | -8.96% Low |
200-day | -5.27% Low | 34.99% Mid | -4.10% Low |
Choose Metric type
Select Performance timeframe above to analyze
On 2024-Dec-19, AbbVie, Inc. had:daily change of -0.87% intraday volatility of 2.1% 2 ↓ (down) day streak yielding -2.20% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2024-Dec-19 value annotated for comparison
Related to AbbVie, Inc.
Information for AbbVie, Inc.
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Mar-11 on Google
SEC Reports : Quarterly reports around 2025-Mar-11 on SEC Edgar
Compare AbbVie, Inc. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes AbbVie, Inc.
Industry : Pharmaceuticals industry performance which includes AbbVie, Inc.